229 related articles for article (PubMed ID: 24730580)
1. Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.
Chu UB; Vorperian SK; Satyshur K; Eickstaedt K; Cozzi NV; Mavlyutov T; Hajipour AR; Ruoho AE
Biochemistry; 2014 May; 53(18):2956-65. PubMed ID: 24730580
[TBL] [Abstract][Full Text] [Related]
2. Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats.
Glynos NG; Carter L; Lee SJ; Kim Y; Kennedy RT; Mashour GA; Wang MM; Borjigin J
Sci Rep; 2023 Jan; 13(1):280. PubMed ID: 36609666
[TBL] [Abstract][Full Text] [Related]
3. Rabbit lung indolethylamine N-methyltransferase. cDNA and gene cloning and characterization.
Thompson MA; Weinshilboum RM
J Biol Chem; 1998 Dec; 273(51):34502-10. PubMed ID: 9852119
[TBL] [Abstract][Full Text] [Related]
4. Indolethylamine-
Dean JG
Front Neurosci; 2018; 12():232. PubMed ID: 29740267
[No Abstract] [Full Text] [Related]
5. Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization.
Thompson MA; Moon E; Kim UJ; Xu J; Siciliano MJ; Weinshilboum RM
Genomics; 1999 Nov; 61(3):285-97. PubMed ID: 10552930
[TBL] [Abstract][Full Text] [Related]
6. Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer.
Zhong S; Jeong JH; Huang C; Chen X; Dickinson SI; Dhillon J; Yang L; Luo JL
J Exp Clin Cancer Res; 2021 Sep; 40(1):307. PubMed ID: 34587977
[TBL] [Abstract][Full Text] [Related]
7. Search for new treatment approaches in schizophrenia: in vitro studies of potential N-methyltransferase inhibitors.
Domino EF
Arch Int Pharmacodyn Ther; 1976 May; 221(1):75-86. PubMed ID: 1067060
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships among desmethyl derivatives of neuroleptics and antidepressants for substrate specificty to indolethylamine N-methyltransferase from rabbit lung.
Narasimhachari N; Lin RL
Psychopharmacol Commun; 1976; 2(1):27-38. PubMed ID: 8818
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain.
Dean JG; Liu T; Huff S; Sheler B; Barker SA; Strassman RJ; Wang MM; Borjigin J
Sci Rep; 2019 Jun; 9(1):9333. PubMed ID: 31249368
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic insight for the biosynthesis of N,N-dimethyltryptamine: An ONIOM theoretical approach.
Coutinho LP; Silva SRB; de Lima-Neto P; Monteiro NKV
Biochem Biophys Res Commun; 2023 Oct; 678():148-157. PubMed ID: 37640000
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of product inhibition of rabbit lung N-methyltransferase.
Krause RR; Domino EF
Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):359-74. PubMed ID: 4531088
[No Abstract] [Full Text] [Related]
12. Human indole(ethyl)amine-N-methyltransferase (hINMT) catalyzed methylation of tryptamine, dimethylsulfide and dimethylselenide is enhanced under reducing conditions - A comparison between 254C and 254F, two common hINMT variants.
Torres B; Tyler JS; Satyshur KA; Ruoho AE
PLoS One; 2019; 14(7):e0219664. PubMed ID: 31310642
[TBL] [Abstract][Full Text] [Related]
13. N-methylation of 1-methyltryptamines by indolethylamine N-methyltransferase.
Lin R; Narasimhachari N
Biochem Pharmacol; 1975 Jun; 24(11-12):1239-40. PubMed ID: 1056183
[No Abstract] [Full Text] [Related]
14. Differential molecular mechanisms of substrate recognition by selenium methyltransferases, INMT and TPMT, in selenium detoxification and excretion.
Fukumoto Y; Kyono R; Shibukawa Y; Tanaka YK; Suzuki N; Ogra Y
J Biol Chem; 2024 Feb; 300(2):105599. PubMed ID: 38159853
[TBL] [Abstract][Full Text] [Related]
15. Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells.
Tourino MC; de Oliveira EM; Bellé LP; Knebel FH; Albuquerque RC; Dörr FA; Okada SS; Migliorini S; Soares IS; Campa A
Cell Biochem Funct; 2013 Jul; 31(5):361-4. PubMed ID: 23754498
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydrofolic acid: an inhibitor of the methyltetrahydrofolic acid-mediated methylation of indolethylamines.
Lin RL; Narasimhachari N
Biochim Biophys Acta; 1975 Apr; 385(2):268-74. PubMed ID: 1055009
[TBL] [Abstract][Full Text] [Related]
17. In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine.
Vitale AA; Pomilio AB; Cañellas CO; Vitale MG; Putz EM; Ciprian-Ollivier J
J Nucl Med; 2011 Jun; 52(6):970-7. PubMed ID: 21622895
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dimethyltryptamine biosynthesis by N,N'-bis-(3-methyl-2-thiazolidinylidene)succinamide (I) and 2-imino-3-methylthiazolidine (II).
Mandel LR; Rokach J; Rooney CS; Cragoe EJ
Mol Pharmacol; 1978 Sep; 14(5):930-9. PubMed ID: 280749
[No Abstract] [Full Text] [Related]
19. N,N-Dimethyltryptamine Production in Phalaris aquatica Seedlings: A Mathematical Model for its Synthesis.
Mack JP; Mulvena DP; Slaytor M
Plant Physiol; 1988 Oct; 88(2):315-20. PubMed ID: 16666301
[TBL] [Abstract][Full Text] [Related]
20. Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues.
Kärkkäinen J; Forsström T; Tornaeus J; Wähälä K; Kiuru P; Honkanen A; Stenman UH; Turpeinen U; Hesso A
Scand J Clin Lab Invest; 2005; 65(3):189-99. PubMed ID: 16095048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]